BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 19040777)

  • 41. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.
    Apostolakis E; Papakonstantinou NA; Baikoussis NG; Papadopoulos G
    J Anesth; 2015 Feb; 29(1):112-21. PubMed ID: 24981564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis.
    Visser LH
    Eur J Neurol; 2006 Nov; 13(11):1203-12. PubMed ID: 17038033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiology and management of critical illness polyneuropathy and myopathy.
    Cheung K; Rathbone A; Melanson M; Trier J; Ritsma BR; Allen MD
    J Appl Physiol (1985); 2021 May; 130(5):1479-1489. PubMed ID: 33734888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
    Frithiof R; Rostami E; Kumlien E; Virhammar J; Fällmar D; Hultström M; Lipcsey M; Ashton N; Blennow K; Zetterberg H; Punga AR
    Clin Neurophysiol; 2021 Jul; 132(7):1733-1740. PubMed ID: 33875374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy.
    Bird SJ
    Curr Treat Options Neurol; 2007 Mar; 9(2):85-92. PubMed ID: 17298769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review.
    Intiso D; Centra AM; Bartolo M; Gatta MT; Gravina M; Di Rienzo F
    BMC Neurol; 2022 Feb; 22(1):50. PubMed ID: 35148710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L; Villadóniga M; González-Rodríguez L; Araque L; Díaz-Cid A; Ruz-Caracuel I; Pian H; Sánchez-Alonso S; Fanjul S; Del Álamo M; Regidor I
    Clin Neurophysiol; 2020 Dec; 131(12):2809-2816. PubMed ID: 33137571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurological complications of sepsis: critical illness polyneuropathy and myopathy.
    Hund E
    J Neurol; 2001 Nov; 248(11):929-34. PubMed ID: 11757954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of Critical Illness Myopathy and Neuropathy.
    Shepherd S; Batra A; Lerner DP
    Neurohospitalist; 2017 Jan; 7(1):41-48. PubMed ID: 28042370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course.
    Ahlbeck K; Fredriksson K; Rooyackers O; Måbäck G; Remahl S; Ansved T; Eriksson L; Radell P
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):717-23. PubMed ID: 19388901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of critical illness polyneuropathy and myopathy.
    Chawla J; Gruener G
    Neurol Clin; 2010 Nov; 28(4):961-77. PubMed ID: 20816273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes of critical illness polyneuropathy.
    Kane SL; Dasta JF
    Pharmacotherapy; 2002 Mar; 22(3):373-9. PubMed ID: 11898892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical illness associated neuromuscular disorders -- keep them in mind.
    Nemes R; Molnár L; Fülep Z; Fekete K; Berhés M; Fülesdi B
    Ideggyogy Sz; 2014 Nov; 67(11-12):364-75. PubMed ID: 25720238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromuscular complications of critical illness.
    Osias J; Manno E
    Crit Care Clin; 2014 Oct; 30(4):785-94. PubMed ID: 25257741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuromuscular sequelae of critical illness.
    Latronico N; Shehu I; Seghelini E
    Curr Opin Crit Care; 2005 Aug; 11(4):381-90. PubMed ID: 16015120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical illness-associated weakness and related motor disorders.
    Younger DS
    Handb Clin Neurol; 2023; 195():707-777. PubMed ID: 37562893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term neuromuscular sequelae of critical illness.
    Semmler A; Okulla T; Kaiser M; Seifert B; Heneka MT
    J Neurol; 2013 Jan; 260(1):151-7. PubMed ID: 22820684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weakness in the ICU: Guillain-Barré syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy.
    Green DM
    Neurologist; 2005 Nov; 11(6):338-47. PubMed ID: 16286877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.